TOKYO -- Japan's Takeda Pharmaceutical, America's Pfizer, British-Swedish multinational AstraZeneca and seven other big drugmakers plan to jointly support reducing the greenhouse gas emissions of their suppliers in an attempt to join the global trend toward decarbonization, Nikkei has learned.
U.K.-based GSK, the U.S.'s Johnson & Johnson and Swiss giant Novartis will also participate.
